News

Fierce Pharma21h
With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant
After unveiling a new drug substance facility in North Carolina in December, Amgen is doubling down on expanding its U.S. | ...
Fierce Pharma19h
Summit stock crashes as Akeso shares bispecific's first overall survival data in Keytruda head-to-head trial
Akeso has shared for the first time overall survival data from a high-profile Keytruda head-to-head trial for its PD-1xVEGF ...
Fierce Pharma23h
Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years
With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...